Covid-19 Boosters — Where from Here? | NEJM - nejm.org

Editorial from The New England Journal of Medicine — Covid-19 Boosters — Where from Here?

On December 10, 2020, Pfizer presented results from a 36,000-person, two-dose, prospective, placebo-controlled trial of its Covid-19 messenger RNA (mRNA) vaccine, BNT162b2, to the Food and Drug Admin… [+5042 chars]

full article...